Why would human tissues be used by pharmaceutical and biotech companies as part of their pre-clinical research? Where do they get the tissue from? How do the logistics work? What is key benefits and limitations of using this type of research? This and many more questions will be addressed by my guest David Bunton, CEO of Reprocell Europe, who in line with the theme of this podcast, lives and works in Scotland.